| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ffd5528fd07384d7b07ab484ed5b143 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2001-1056 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N23-00 |
| filingDate |
2021-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_130aec3d67d7c5d74bce88c81166a162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a48d4815e9fb39290ddc2bcb1fea7ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0c2f601aa9d5239c87b8bc525d58fe8 |
| publicationDate |
2022-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022283160-A1 |
| titleOfInvention |
Methods and systems for rapid detection of sars-cov-2 using a radiolabeled antibody |
| abstract |
The present disclosure relates to methods and kits for detecting SARS-CoV-2 virus in a patient. For example, a method is disclosed that includes contacting at least a portion of a diluted saliva sample, the diluted saliva sample including a saliva sample from a patient and a saline solution, with a radiolabeled SARS-CoV-2-targeted antibody to form a first solution that includes target bound antibody and unbound antibody; separating at least a portion of the target bound antibody from the unbound antibody in the first solution to form a separated target bound antibody solution; and detecting a radiation level in the separated target bound antibody sample indicating the presence of the target bound antibody in the separated target bound antibody sample. |
| priorityDate |
2021-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |